Showing 8211-8220 of 8647 results for "".
- Schwind Introduces WiseNET Intelligent Web-Based Databasehttps://modernod.com/news/schwind-introduces-wisenet-intelligent-web-based-database/2476554/Schwind WiseNET is a web-based database that allows the user to capture and evaluate refractive treatment data quickly and precisely, and present it graphically for all sorts of uses in daily clinical work. Diagrams s
- Leiters Now Integrated into Besse Medical’s Inventory Management Systemshttps://modernod.com/news/leiters-now-integrated-into-besse-medicals-inventory-management-systems/2476547/Leiters and Besse Medical announced that they have entered into a national agreement to provide ophthalmic medications that are compatible with Besse Medical’s inventory management systems, CubixxMD and PODIS Plus. This new agreement enables Leiters’ full suite of ophthalmic medicatio
- SightGlass Vision Presents Clinical Trial Data From Novel Lenses to Control Myopiahttps://modernod.com/news/sightglass-vision-presents-clinical-trial-data-from-novel-lenses-to-control-myopia/2476541/SightGlass Vision announced that data assessing the tolerability of three iterations of its novel lenses designed to control nearsightedness in children were presented at the Association for Research in Vision and
- New President/CEO at The Glaucoma Foundationhttps://modernod.com/news/new-president-ceo-at-the-glaucoma-foundation/2476529/The Board of Directors of The Glaucoma Foundation (TGF) has announced the appointment of Elena Sturman as President and Chief Executive Officer, following the retirement of Scott R. Christensen, who held the position since 2002. She wi
- Jim Wachtman Joins CorneaGen as Chief Commercial Officerhttps://modernod.com/news/jim-wachtman-joins-corneagen-as-chief-commercial-officer/2476527/CorneaGen announced that James “Jim” C. Wachtman has joined the young company as chief commercial officer. Mr. Wachtman has been a leader in the cornea community for 20 years and serves as the chair of the Refractive Surgery Council, a group of industry manufacturers and ophthalmologists focused
- Clearside Biomedical’s Suprachoroidal Space Injection Platform Featured at Multiple Ophthalmology and Gene Therapy Medical Meetingshttps://modernod.com/news/clearside-biomedicals-suprachoroidal-space-injection-platform-featured-at-multiple-ophthalmology-and-gene-therapy-medical-meetings/2476524/Clearside Biomedical announced that multiple presentations were made on Clearside’s Suprachoroidal Space (SCS) injection platform at ophthalmology and gene therapy medical meetings in Vancouver, British Columbia. The presentations highlighted the potential benefits of Clearside’s SCS injection pl
- Verseon Presents Oral Drug Candidate for Diabetic Eye Diseasehttps://modernod.com/news/verseon-presents-oral-drug-candidate-for-diabetic-eye-disease/2476516/Verseon presented promising preclinical efficacy data for the first development candidate for clinical trials in their diabetic eye disease program at this week’s ARVO 2019 annual meeting in Vancouver. This new drug candidate for oral dosing could lead to the first real alternative to eye injecti
- RadianceTx Expands Team to Develop Beta Ophthalmic Systemhttps://modernod.com/news/radiancetx-expands-team-to-develop-beta-ophthalmic-system/2476511/Radiance Therapeutics has announced the expansion of its core team. Abigail Mackrill, formerly of Ophthalmology Futures Forums and The Ophthalmologist, joins as Director of Business Development and Outreach. James Fazio, MBA, Msc Eng, formerly Global Business Leader for
- Roche Further Extends Tender Offer for Spark Therapeutics as FTC Review Continueshttps://modernod.com/news/roche-further-extends-tender-offer-for-spark-therapeutics-as-ftc-review-continues/2476508/Roche said Friday that it is extending its offer period related to the proposed acquisition of Spark Therapeutics for a second time to give the US Federal Trade Commission (FTC) more time to review the deal, according to FirstWord. Roche noted that the FTC’s “review of the transaction
- Implandata Gains CE Mark for its Eyemate System for Keratoprosthesishttps://modernod.com/news/implandata-gains-ce-mark-for-its-eyemate-system-for-keratoprosthesis/2476510/Ophthalmic sensors and digital health company Implandata Ophthalmic Products announced that it attained CE mark for its Eyemate system for use in patients undergoing keratoprosthesis surgery. Keratoprosthesis represents an infrequent yet important procedure for restoring vision. It is performed o